--- title: "Zevra Therapeutics (ZVRA.US) — Financial Reports" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/ZVRA.US/norm.md" symbol: "ZVRA.US" name: "Zevra Therapeutics" parent: "https://longbridge.com/en/quote/ZVRA.US.md" datetime: "2026-03-15T19:48:24.299Z" locales: - [en](https://longbridge.com/en/quote/ZVRA.US/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/ZVRA.US/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/ZVRA.US/norm.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/ZVRA.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/ZVRA.US/norm.md) # Zevra Therapeutics (ZVRA.US) — Financial Reports ## Income Statement (USD) | Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | | --- | --- | --- | --- | --- | --- | | EPS | 0.1948 | -0.0100 | 1.23 | -0.0573 | -0.6684 | | ROE | 32.88% | -1.74% | 350.82% | -30.73% | -261.26% | | Revenue | 34.13M | 26.06M | 25.88M | 20.40M | 12.04M | | Net income | 11.83M | -544000.00 | 69.40M | -3.10M | -35.74M | | Operating income | 9.31M | 4.14M | -12.33M | -5.36M | -15.42M | | Gross margin | 95.55% | 95.25% | 52.17% | 93.41% | 88.66% | | Net margin | 35.65% | -2.09% | 288.66% | -15.19% | -296.76% | | Profit quality | 168.87% | 87.98% | - | - | - | ## Balance Sheet (USD) | Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | | --- | --- | --- | --- | --- | --- | | A&L | 284.73M | 270.12M | 256.28M | 172.71M | 178.13M | | Leverage | 1.84 | 2.03 | 2.19 | 4.21 | 4.49 | | BVPS | 2.72 | 2.37 | 2.13 | 0.7502 | 0.7391 | | Turnover | 0.4601 | 0.3656 | 0.3096 | 0.2506 | 0.1348 | | Cash & STI | 191.01M | 199.51M | 202.61M | 62.63M | 69.50M | | Inv & Rec | 1.74M | 1.37M | 1.11M | 2.56M | 1.97M | | LT assets | 1.70M | 1.82M | 2.10M | 2.06M | 1.01M | | Net debt | -127.81M | -136.79M | -140.34M | -794000.00 | -9.20M | ## Cash Flow Statement (USD) | Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | | --- | --- | --- | --- | --- | --- | | Operating CF | 5.52M | 4.71M | -3.60M | -8.22M | -16.25M | | Investing CF | 227000.00 | -4.58M | 11.93M | 10.54M | -5.47M | | Financing CF | 2.55M | 6.53M | 1.38M | 1.61M | 796000.00 | | Free CF | 17.30M | 682375.00 | -6.67M | -8.28M | -10.65M | | OCF coverage | -17793.55% | 850.00% | -1690.61% | -1745.65% | - | | Repaid & issued | - | - | - | - | 0.0000 | | CapEx | 31000.00 | -554000.00 | -213000.00 | -99000.00 | - |